(Reuters) -The U.S. Food and Drug Administration have missed the deadline for making a key decision on Novavax’s COVID-19 vaccine, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shreya Biswas)
